PharMEDium Healthcare officially withdraws $100 million IPO; acquired by AmerisourceBergen for $2.58 billion

PharMEDium Healthcare Holdings, a national provider of compounded sterile preparations to acute care hospitals, withdrew its plans for an initial public offering on Tuesday. It originally filed in August 2015 with a proposed deal size of $100 million. It was acquired by AmerisourceBergen in a $2.58 billion cash deal first announced in October 2015. The company had been bought by Clayton Dubilier & Rice in January 2014 for a reported $900 million.

The Lake Forest, IL-based company was founded in 2003 and booked $430 million in sales for the 12 months ended June 30, 2015. It had planned to list on the NYSE under the symbol PMHC. Credit Suisse, J.P. Morgan, Morgan Stanley, BofA Merrill Lynch and Goldman Sachs were set to be the joint bookrunners on the deal.